Side-by-side comparison of AI visibility scores, market position, and capabilities
Datavant is the largest health data ecosystem connecting healthcare organizations through privacy-preserving tokenization that enables real-world data linkage across systems.
Datavant is a health data company founded in 2017 that has built the largest real-world health data ecosystem in the United States through its privacy-preserving data tokenization technology. The company's platform enables healthcare organizations including hospitals, insurers, pharmaceutical companies, and research institutions to link patient records across databases without sharing identifying information, using consistent de-identified tokens that allow data to be joined securely. Datavant raised over $600M and expanded significantly through its merger with Ciox Health, combining Datavant's tokenization technology with Ciox's medical record retrieval operations. The company serves life sciences companies that need real-world evidence from claims, EHR, and specialty data sources, payers managing population health programs, and health systems that want to generate revenue from their patient data while maintaining privacy compliance. Datavant's network effect grows as more organizations adopt the tokenization standard, making the ecosystem more valuable for every participant. The platform has become critical infrastructure for real-world evidence generation in pharmaceutical development and health economics research.
Thermo Fisher (TMO) reported $42.9B revenue in FY2024, down 1% YoY. World's #1 life sciences company. Serves pharma, biotech, labs globally. ~100,000 employees. HQ: Waltham, MA.
Thermo Fisher Scientific Inc. is the world's largest life sciences company, providing analytical instruments, reagents, consumables, software, and services to researchers, healthcare organizations, and industrial companies. Headquartered in Waltham, Massachusetts, Thermo Fisher was formed through the 2006 merger of Thermo Electron and Fisher Scientific and has since grown aggressively through acquisitions. The company reported revenues of $42.9B in FY2024, slightly down year-over-year after exceptional COVID-related revenue in 2021–2022.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.